NLRP3-mediated inflammasome activation by Escherichia coli isolated from patients with and without inflammatory bowel disease

被引：0
|
作者：
Martin, N. [1 ]
Das Gupta, M. [2 ]
Mathur, A. [2 ]
Hayward, J. [2 ]
Ngo, C. [2 ]
Man, S. [2 ]
O'Brien, C. [2 ]
机构：
[1] Canberra Hosp, Canberra, ACT, Australia
[2] Australian Natl Univ, Canberra, ACT, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
455
引用
收藏
页码：112 / 113
页数：2
相关论文
共 50 条
  • [21] Comparative genomics of a subset of Adherent/Invasive Escherichia coli strains isolated from individuals without inflammatory bowel disease
    Barrios-Villa, Edwin
    Martinez de la Pena, Claudia Fabiola
    Lozano-Zarain, Patricia
    Cevallos, Miguel A.
    Torres, Carmen
    Torres, Alfredo G.
    del Carmen Rocha-Gracia, Rosa
    GENOMICS, 2020, 112 (02) : 1813 - 1820
  • [22] Impairment of alternative NLRP3 inflammasome pathway in peripheral blood monocytes from inflammatory bowel disease patients
    Sanchez Rodriguez, Carlos
    Hurtado Blanco, Pablo
    Otalora, Almudena
    Salgado Cecilia, Gema
    Moya Quiles, Rosa
    Galian Megias, Jose Antonio
    Anton Rodenas, Gonzalo
    Muro Amador, Manuel
    Martinez Banaclocha, Helios
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1162 - 1162
  • [23] Porphyromonas gingivalis triggers NLRP3-mediated inflammasome activation in macrophages in a bacterial gingipains-independent manner
    Okano, Tokuju
    Ashida, Hiroshi
    Suzuki, Shiho
    Shoji, Mikio
    Nakayama, Koji
    Suzuki, Toshihiko
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 (12) : 1965 - 1974
  • [24] The Chinese medicine babaodan suppresses LPS-induced sepsis by inhibiting NLRP3-mediated inflammasome activation
    Li, Yu-Fei
    Sheng, Hong-da
    Qian, Jing
    Wang, Yi
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 292
  • [25] Differentiation of Escherichia fergusonii and Escherichia coli Isolated from Patients with Inflammatory Bowel Disease/Ischemic Colitis and Their Antimicrobial Susceptibility Patterns
    Dahal, Ram Hari
    Choi, Yoon-Jung
    Kim, Shukho
    Kim, Jungmin
    ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [26] Presence of intracellular Escherichia coli in patients with inflammatory bowel disease
    De la Fuente, Marjorie
    Chahuan, Isidora
    Gutierrez, Rocio
    Diaz-Jimenez, David
    Olivares, Mauricio
    Vidal, Roberto
    Simian, Daniela
    Figueroa, Carolina
    Quera, Rodrigo
    Hermoso, Marcela A.
    REVISTA MEDICA DE CHILE, 2017, 145 (09) : 1129 - 1136
  • [27] Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease
    Song, Yijie
    Zhao, Yuge
    Ma, Yueming
    Wang, Zhicheng
    Rong, Lan
    Wang, Bing
    Zhang, Ning
    CYTOKINE & GROWTH FACTOR REVIEWS, 2021, 60 : 61 - 75
  • [28] Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease
    Chen, Qiu-Ling
    Yin, Hao-Ran
    He, Qing-Yu
    Wang, Ying
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 138
  • [29] Distinct inflammatory and cytopathic characteristics of Escherichia coli isolates from inflammatory bowel disease patients
    Jensen, Stina Rikke
    Mirsepasi-Lauridsen, Hengameh Chloe
    Thysen, Anna Hammerich
    Brynskov, Jorn
    Krogfelt, Karen A.
    Petersen, Andreas Munk
    Pedersen, Anders Elm
    Brix, Susanne
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 305 (08) : 925 - 936
  • [30] Bushen Huoxue formula protects against renal fibrosis and pyroptosis in chronic kidney disease by inhibiting ROS/NLRP3-mediated inflammasome activation
    Liao, Lin
    Tao, Pengyu
    Xu, Qiming
    Chen, Jie
    Liu, Weiwei
    Hu, Jing
    Lu, Jianrao
    RENAL FAILURE, 2024, 46 (01)
12345